To include your compound in the COVID-19 Resource Center, submit it here.
Takeda will acquire Nycomed for €9.6 billion ($13.6 billion) in cash. The boards of both companies approved the deal,
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury